CANNAPHARMARX, INC. Liabilities Subject to Compromise, Debt and Accrued Interest
CANNAPHARMARX, INC. (CPMD) had Liabilities Subject to Compromise, Debt and Accrued Interest of $1.04 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes
us-gaap:LiabilitiesSubjectToCompromiseDebtAndAccruedInterest · last filed 2026-03-31
- 2025-12-31: Liabilities Subject to Compromise, Debt and Accrued Interest $1.04M.
- 2025-09-30: Liabilities Subject to Compromise, Debt and Accrued Interest $1.06M.
- 2024-12-31: Liabilities Subject to Compromise, Debt and Accrued Interest $597.87K.
| Period end | Liabilities Subject to Compromise, Debt and Accrued Interest |
|---|---|
| 2025-12-31 | $1.04M 10-K · filed 2026-03-31 |
| 2025-09-30 | $1.06M 10-Q · filed 2025-11-14 |
| 2024-12-31 | $597.87K 10-K · filed 2026-03-31 |